MRTX

Mirati Therapeutics, Inc. Common Stock
MRTX

Overview Fund Activity
Delisted

MRTX was delisted on the 22nd of January, 2024.

Back to rankings

230 hedge funds and large institutions have $3.95B invested in Mirati Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 110 increasing their positions, 60 reducing their positions, and 54 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
230
Holders Change
-22
Holders Change %
-8.73%
% of All Funds
3.89%
Holding in Top 10
13
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+44.44%
% of All Funds
0.22%
New
36
Increased
110
Reduced
60
Closed
54
Calls
$95.4M
Puts
$24M
Net Calls
+$71.4M
Net Calls Change
+$46.1M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
$164M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
$57.2M
3
Morgan Stanley
Morgan Stanley
New York
$60.8M
4
Bank of Nova Scotia
Bank of Nova Scotia
Ontario, Canada
$56.5M
5
PBA
Paradigm Biocapital Advisors
New York
$44.3M

Top Sellers

1
APM
Avidity Partners Management
Texas
$0
2
Holocene Advisors
Holocene Advisors
New York
$0
3
RCM
RA Capital Management
Massachusetts
$0
4
EC
EcoR1 Capital
California
$0
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$70.6M
Name Holding Trade Value Shares
Change 		Shares
Change %
UB
276
UMB Bank
Missouri
– -$2K -23 Closed
Kayne Anderson Rudnick Investment Management
277
Kayne Anderson Rudnick Investment Management
California
– -$1K -12 Closed
PCA
278
Providence Capital Advisors
North Carolina
– -$1K -11 Closed
WT
279
Whittier Trust
California
– -$1K -11 Closed
SPIA
280
Steward Partners Investment Advisory
New York
– -$1K -8 Closed
8 9 10 11
12